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Abstract We analyzed the influence of the kind of cytotox-
icity test and its application modality in defining the level of
hazard of the in vitro exposures to nanostructures. We
assessed the cytotoxicity induced by two different Ludox®
silica nanoparticles (NPs), AS30 and SM30, on three human
cell lines, CCD-34Lu, A549, and HT-1080. Dynamic light
scattering measurements showed particle agglomeration
when NPs are diluted in culture medium supplemented with
fetal calf serum. We examined the impact of such particle
aggregation on the cytotoxicity by exposing the cells to NPs
under different treatment modalities: short incubation (2 h)
in serum-free medium or long incubation (24–72 h) in
serum-containing medium. Under this last modality, NP
suspensions tended to form aggregates and were toxic at
concentrations five- to tenfold higher than in serum-free
medium. The results of cell survival varied considerably
when the long-term clonogenic assay was performed to
validate the data of the short-term MTS assay. Indeed, the
half maximum effective concentrations (EC50) in all the
three cell lines were four- to fivefold lower when calculated
from the data of clonogenic assay than of MTS. Moreover,
the mechanisms of NP toxicity were cell-type-specific,
showing that CCD-34Lu are prone to the induction of plas-
ma membrane damages and HT-1080 are prone to DNA
double-strand break and apoptosis induction. Taken togeth-
er, our results demonstrate that the choice of testing strategy
and treatment conditions plays an important role in assess-
ing the in vitro toxicity of NPs.
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Introduction
Nanoparticles (NPs) are particulate structures of various
shapes and different compositions with a 1–100 nm size.
These structures possess unique and innovative physical and
chemical properties, determined by their nanoscale dimen-
sions and especially by the high-ratio surface area/volume
that give to the NPs a new chemical reactivity and new
optical, magnetic, catalytic, and electrochemical properties.
In the last decades, these characteristics have made the NPs
of considerable interest in technological development and
widely used in medicine and diagnostics [1], in biotechnol-
ogy [2, 3], and in cosmetics, food, and materials [4]. Silica
NPs (SiO2) have found extensive applications in industrial
manufacturing, packaging, chemical industry, and as addi-
tives to drugs, cosmetics, printer toners, and food. In recent
years, the use of silica nanoparticles has been extended to
biomedical and biotechnological fields, such as biosensors
or biomarkers for optical microscopy imaging [5], cancer
therapy [6], DNA delivery [7, 8], and drug delivery [9].
However, the increasing exposure to nanoscale particles
requires studies that characterize their properties and poten-
tial cytotoxic effects in order to provide exhaustive infor-
mation for the assessment of the impact of nanomaterials on
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human health and the consequent regulation of their use. To
date, several studies have shown the cytotoxicity of silica
nanoparticles in vitro and in vivo. These reports demonstrat-
ed that exposure to SiO2 NPs can cause decrease of cell
viability as a function of size, dose, and time of exposure
[10–12] and in a surface area-dependent manner in human
primary endothelial cells [13]. A size-, dose-, and time-
dependent cytotoxicity related to oxidative stress has been
observed in human cells exposed to SiO2 NPs [12, 14–17],
together with oxidative stress-driven apoptosis [12, 18].
Silica NPs have the ability to induce inflammatory
responses in cultured primary human pulmonary fibroblasts
[19], in human endothelial cells [20] and in mouse macro-
phage cell line [21], as well as to induce cell cycle arrest in
human myocardial and in embryonic kidney cells [11, 22].
In vivo exposure to SiO2 NPs caused hepatotoxicity [23],
liver injury [24], pregnancy complications [25], increased
level of pro-inflammatory cytokines in mice [21], and pul-
monary and cardiovascular damage with ischemic disorders
in old rats [26]. Moreover, silica nanoparticles that enter the
nucleus induce the formation of protein aggregates, inhibit-
ing DNA replication and transcription [27]. Along with size,
dose, and incubation time, differences in cytotoxicity in-
duced by silica nanoparticles have been detected in relation
to the presence of serum in culture medium. The adsorption
of serum proteins to the silica surface could result in altered
compatibility and uptake into the cells [28, 29]. Indeed, the
serum-driven agglomeration of primary NPs to larger sec-
ondary NPs affects cell viability [30], with important impli-
cations for the evaluation of the cytotoxic potential of silica
NPs, as well as other nanomaterials in standard cell cultures.
In the present study, we explored the toxicity induced by
in vitro incubation of three human cell lines with the com-
mercial AS30 and SM30 Ludox® nanoparticles. These col-
loidal amorphous silica NPs are widely used in various
industrial fields, such as in the production of printer’s inks
and paints, in textile industry, and in food industry for the
fining of drinks. Two of the three cell lines used in our
experiments are epithelial cells originated from lungs,
A549 cancer cells, and CCD-34Lu normal fibroblasts, cho-
sen because the entry through the respiratory tract is one of
the most frequent routes by which nanomaterials may enter
the body. The third cell line, HT-1080, derived from human
fibrosarcoma, is also used to test the cytotoxicity of nano-
materials [31–34]. We exposed the cells to different treat-
ment modalities, in order to evaluate the influence of serum
and the incubation time on Ludox® NPs cytotoxicity. We
compared short-time incubation in serum-free medium and a
long-time incubation in medium supplemented with serum
on the toxicity induced by Ludox® NPs using different
assays. Cell viability testing was carried out with the widely
used short-term assay (MTS) and the long-term clonogenic
assay to obtain a more accurate estimation of the potential
toxicity of Ludox® NPs. Our results demonstrate that
the choice of the experimental conditions and the tox-
icity testing protocols plays a relevant role in determin-




Ludox® nanoparticles were obtained from Sigma-Aldrich
(Milan, Italy). Ludox® is a registered trademark of W.R.
Grace & Co.-Conn. Fetal calf serum (FCS) and 0.05 %
trypsin–0.53 mM EDTA were purchased from Gibco (Invi-
trogen, Italy). F-12 K medium, Dulbecco’s modified Eagle’s
medium (DMEM, 0.2 M GlutaMAX, 4.5 g/L glucose) and
minimum essential medium (MEM, Earl's salt, L-glutamine)
were provided by Gibco (Invitrogen). Penicillin–streptomy-
cin, formaldehyde, RNase, sodium pyruvate, TPEN (N,N,N',
N'-tetrakis-(2-pyridylmethyl)-ethylenediamine), HEPES (4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid), Triton
X-100, and propidium iodide were obtained from Sigma-
Aldrich. Goat serum, Hank's balanced salt solution (HBSS),
non-essential amino acids (NEAA) 100×, mounting medium
Vectashield, carboxy-H2DCFDA (carboxy-2′,7′-dichloro-
fluorescein diacetate) probe were purchased from Invitro-
gen. DAPI (4',6-diamidino-2-phenylindole) was obtained
from Roche Diagnostics (Indianapolis, IN, USA). Anti-γ-
H2AX mouse monoclonal antibody was purchased from
Upstate, Millipore (Billerica, MA, USA) and from Molecu-
lar Probes (Alexa Fluor, Life Technologies, Carlsbad, CA,
USA). CellTiter 96®AQueous One Solution Proliferation
Assay kit for MTS assay was purchased from Promega
(Milan, Italy); ApoAlertCaspase Fluorescent Assay kit was
provided by Clontech (Milan, Italy). Annexin-V-FLUOS
Staining Kit was bought from Roche Applied Science (Indi-
anapolis, IN, USA). Solvents and commercially available
reagents were used as received. Ultrapure deionized water
(R>18 MΩ) was prepared using a Milli-Q system
(Millipore).
Ludox® nanoparticles
Ludox® silica nanoparticles of two different sizes, AS30
(ammonium counterion) and SM30 (sodium counterion),
were obtained by the commercial source as 30 wt.% sus-
pension in H2O. The nanoparticle suspensions were diluted
with ultrapure water (Milli-Q) to the desired concentration
(30–40 mg/mL), extensively dialyzed into a 75-mL Amicon
ultrafiltration cell, equipped with a 10-kDa regenerated cel-
lulose membrane, and finally filtered with 0.22 μm Dura-
pore membrane. Nanoparticle concentration in the purified
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sample was determined by weighing a dried aliquot of the
solution.
Transmission electron microscopy (TEM) images of the
particles were obtained with a FeiTecnai 12 transmission
electron microscope operating at 100 keV. Samples for TEM
were prepared by spreading a droplet of the nanoparticle
solution in water (∼1 mg/mL) onto standard carbon-coated
copper grids (200-mesh). Dimensional analysis of nanopar-
ticles from TEM images was performed by using the Image
J software. No differences were found when nanoparticles
for TEM analysis were diluted with water or phosphate-
buffered saline (PBS) solution.
Dynamic light scattering (DLS) measurements were per-
formed with a Zetasizer NanoS (Malvern) equipped with a
thermostatic cell holder and Ar laser operating at 633 nm.
Hydrodynamic particle diameters were obtained from cumu-
lant fit of the autocorrelation functions at 178° scattering
angle. Size measurements were performed at 37 °C. DLS
measurements where performed only in PBS and in cell
culture medium, with or without 3 % of FCS, because the
electric double layer produced by the highly negative sur-
face charge of the nanoparticles hampers reliable measure-
ments in pure water.
For the stability tests, Ludox® NPs AS30 and SM30 were
diluted in water and in cell culture medium, with or without
3 % of FCS, to final concentrations of 0.1 and 1 mg/mL.
Immediately after dilution (0 h) and after 24 h of incubation
at 37 °C, the absorption of the suspensions was recorded in
the 200–800 nm range. For DLS analyses, NPs were diluted
in PBS or in cell culture medium with or without 3 % of
FCS, and three size measurements were performed for each
sample after 2 h incubation at 37 °C. For cytotoxicity tests,
the dialyzed NP stock suspensions were diluted with ultra-
pure water (5 mg/mL); the pH was adjusted between 7.3 and
7.5 with 1 M HCl, and the suspensions were sterilized by
filtration with 0.22 μm (control experiment confirm that
such operations do not alter the nanoparticles concentra-
tion). The diluted solutions were prepared immediately be-
fore use.
Cell lines
The human cell lines A549 (lung adenocarcinoma), CCD-
34Lu (normal lung fibroblasts), and HT-1080 (fibrosarcoma)
were obtained from American Type Culture Collection
(ATCC, Rockville, USA) and cultured in monolayer. A549,
CCD-34Lu, and HT-1080 cells were maintained respectively
in F12-K medium, DMEM supplemented with 0.1 mM
NEAA, and 20 mM HEPES, and MEM medium supple-
mented with 0.1 mM NEAA and 1 mM sodium pyruvate.
All culture media were supplemented with 10 % heat-
inactivated FCS, 38 units/ml streptomycin, and 100 units/ml
penicillin G in standard culture conditions and during the post-
treatment recovery (complete medium). Cells were kept at
37 °C in a humidified atmosphere containing 5 % CO2.
NPs treatments
To evaluate the cytotoxicity induced by Ludox® NPs, the
cells were plated and allowed to attach for 24 h. Then, NPs
were diluted to appropriate concentrations and immediately
applied to the cells. We used two modalities of treatment:
long incubation for 24, 48, or 72 h in culture medium
supplemented with 3 % FCS, or short incubation for 2 h in
serum-free medium, followed by a post-treatment recovery
of 3 or 22 h in complete medium (10 % FCS). NP concen-
trations (0.005–0.6 mg/mL) were chosen to evaluate the
dose/survival according to the treatment conditions. Control
cells underwent the same steps of treated cells except for NP
exposure.
Assessment of cytotoxicity
Cytotoxicity induced by Ludox® NPs was evaluated by
the MTS assay which measures the reduction of tetra-
zolium salts to water-soluble formazan product. The
intracellular reduction of MTS is primarily attributable
to mitochondrial dehydrogenases, and therefore this con-
version is conveniently used as a measure of cell via-
bility. Briefly, 8×103 cells/cm2 were seeded in triplicate
in 96-well plates (200 μL/well). After 24 h, the culture
medium was removed, and the cells were incubated
with 150 μL of medium containing different concentra-
tions of AS30 or SM30 NPs. After predetermined incu-
bation time, the medium containing NPs was removed,
and the cells were incubated for 60–90 min in the dark
with 20 μL of the MTS reagent diluted in 100 μL of
serum-free medium. The absorbance of formazan prod-
uct was recorded at 490 nm with a microplate reader
(Spectramax 190, Molecular Device®). Cell viability
was determined by comparing the absorbance values of
the treated with those of untreated cells that were con-
sidered as 100 %. The potential interaction of Ludox
NPs with MTS–formazan crystals has been tested to
exclude any interference with the dye.
The cytotoxicity of NPs was also assessed by clono-
genic assay that measures the ability of single cells to
form colonies. Cells (2–4×104 cell/cm2) were seeded in
6-cm culture dishes and allowed to attach overnight.
Cells were subjected to short and long treatments, har-
vested by trypsinization, and counted by trypan blue
dye exclusion. An appropriate number of viable cells
(10.2 cell/cm2 of cancer cells) was plated in culture
dishes. The 3.2 cell/cm2 CCD-34Lu cells were seeded
together with feeder layer IMR-90 cells (1.9× 103 cell/
cm2) in medium supplemented with 15 % FCS. After 7–
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14 days at 37 °C, the colonies were counted after
staining with 0.4 % crystal violet and counted. Only
colonies containing more than 50 cells were scored as
survivors. Cell survival was calculated as percentage of
cloning efficiency (CE) of treated cells over CE of
control cells. To compare the results obtained by MTS
and clonogenic assays, the cytotoxicity induced by NPs
was expressed as half-maximum effective concentration
(EC50) in milligrams per milliliter [35].
Apoptosis detection
The induction of apoptosis in cells treated with Ludox®
NPs was analyzed by different assays. The Annexin-V-
FLUOS Staining Kit detects the early stage of apoptosis
and allows quantification and differentiation from necro-
sis. Annexin-V–fluorescein is a protein with high affin-
ity for phosphatidylserine (PS), while propidium iodide
crosses only damaged plasma membrane and intercalates
to DNA. Briefly, cells were treated with 0.04 mg/mL
SM30 for 2 h in serum-free medium, and after a recov-
ery of 3 and 22 h in complete medium, the cells were
detached and centrifuged at 200×g for 5 min. The pellet
was resuspended in 100 μL of Annexin-V–Fluos label-
ing solution (20 μL of Annexin-V–Fluos labeling
reagent and 20 μL of propidium iodide solution in
1 mL incubation buffer) and incubated for 10 min at
37 °C. Samples were analyzed by flow cytometry with
a FACSCanto™ II flow cytometer (BD Bioscences, San
Jose, CA, USA).
The formation of apoptotic bodies was investigated by
DAPI staining after treatment with both AS30 or SM30 NPs
(0.04 mg/mL) for 2 h in serum-free medium followed by a
recovery of 22 h in complete medium. After rinsing with
HBSS twice, the cells were fixed (9:1 absolute ethanol/
acetic acid) on ice and centrifuged. This step was repeated
four times. After overnight incubation at 4 °C, cells were
stained with 0.2 μg/mL DAPI. At least 1,000 nuclei for each
time point were inspected by fluorescence microscopy for
detecting the typical morphological appearance of chroma-
tin condensation during the late step of apoptosis with a
Leica DM 5000B microscope (Leica Microsystems).
Apoptosis induction was measured also by the
caspase-3 activation using the ApoAlert® Caspase Fluo-
rescent Assay kit according to manufacturer’s instruc-
tions and as previously described [36]. Cell lysates (1×
106 cells) were prepared at the end of 2 h treatment in
serum-free medium followed by a recovery of 22 h in
complete medium and analyzed with a Perkin-Elmer LS-
50 B spectrofluorimeter. Cells treated for 5 h with
TPEN (N,N,N',N'-tetrakis-(2-pyridylmethyl)-ethylenedi-
amine, 30 μM) were used as positive control.
Reactive oxygen species (ROS) measurements
The production of intracellular reactive oxygen species
(ROS) was measured using the probe 6-carboxy-2′,7′-
dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA).
Cells (CCD-34Lu and A549, 1.8×104 cell/cm2; HT-1080,
7×103 cell/cm2) were seeded in 35-mm-diameter tissue
culture dishes and allowed to attach for 24 h. Thereafter,
the medium was replaced with fresh serum-free medium
containing Ludox® AS30 or SM30 NPs (0.02–0.06 mg/
mL). After 2 h of treatment, the medium was discarded,
and the cells were immediately analyzed for ROS detection
or incubated for 3 or 22 h in complete medium before
analyses. The cells were washed with PBS and incubated
with carboxy-H2DCFDA (25 μM) diluted in PBS for 40 min
at 37 °C in the dark. The cells were washed, harvested, and
then analyzed by a BD FACSCanto II flow cytometer (Bec-
ton Dickinson; Biosciences). The fluorescence intensities
were measured using a 488 nm laser and fluorescein iso-
thiocyanate (FITC) detection channel (530±15 nm) by ac-
quiring 10.000 events/sample. Cells incubated for 2 h in
serum-free medium without NPs were used as negative
controls. The mean fluorescence intensity of cells treated
with NPs (0.02 to 0.06 mg/mL) was expressed as percentage
of controls. Selected samples were also stained with propi-
dium iodide (50 μg/mL, fluorescence detection at 585±
21 nm) to evaluate the integrity of the plasma membrane.
Induction of DNA double-strand breaks
The induction of DNA double-strand breaks (DSBs) by
incubation with NPs was assessed by the presence of γ-
H2AX foci over the nucleus. Cells (7×103 cell/cm2 HT-
1080, 1.2×104 cell/cm2 CCD-34Lu, and A549 cells) were
seeded in 35-mm-diameter tissue culture dishes containing a
glass coverslip and allowed to attach for 24 h. Thereafter,
the cells were treated with AS30 and SM30 NPs (0.01–
0.4 mg/mL) in medium with 3 % serum (24, 48, and
72 h), or in serum-free medium for 2 h, and fixed immedi-
ately at the end of treatments or maintained for 3 or 22 h in
NP-free complete medium. Cells were rinsed twice in PBS
and fixed in formaldehyde 4 % in PBS 1× at 37 °C for
15 min. After washing in PBS, the cells were permeabilized
in 0.2 % Triton X-100 for 10 min at 37 °C and incubated in
10 % goat serum in PBS for 90 min at room temperature to
suppress non-specific antibody binding. The cells were then
incubated for 90 min at room temperature in 30 μL volume
of 10 % goat serum containing 1:200 dilution of phospho-
specific (Ser-139) histone H2AX (γ-H2AX) mouse mono-
clonal antibody. The slides were washed twice with PBS and
then incubated in 30 μL of 10 % goat serum containing
1:250 dilution of Alexa Fluor 488 goat anti-mouse, for 1 h
in the dark. After washing in PBS, the dry samples were
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mounted with mounting medium Vectashield, counter-
stained with DAPI 0.2 μg/mL, and analyzed by fluorescence
microscopy with Leica DM 5000B microscope. At least 100
cells were scored for each time point, and cells with more
than four foci per nucleus were considered positive.
Results
Characterization of Ludox® AS30 and SM30
AS30 and SM30 commercial Ludox® nanoparticles were
selected for two reasons: (1) They have different sizes (see
infra), and (2) they are stabilized by different counterions,
namely ammonium for AS30 and sodium for SM30. Such
differences should allow a better discrimination between
toxicity arising from the silica nanoparticles and from pos-
sible contaminants. In addition, samples from commercial
source were submitted to extensive dialysis to remove any
possible contaminant. DLS and TEM analyses, performed
before and after the dialysis, confirmed that the purification
procedure does not alter the size and morphology of the
nanoparticles. The hydrodynamic diameters, obtained by
DLS, were 20±4 and 14±4 nm for Ludox® AS30 and
SM30, respectively. The mean nanoparticle sizes deter-
mined by TEM micrographs were 18±3 (AS30) and 9±
3 nm (SM30). Zeta potential of both NPs was negatively
charged, −25.9 mVand −26.3 for Ludox® AS30 and SM30,
respectively, indicating that the two preparations of Ludox®
NPs have a similar stability. The data relative to Ludox®
nanoparticles characterization are available (see Electronic
supplementary material Fig. S1).
The behavior of nanoparticles in different media was
preliminarily investigated by incubating NPs in pure water,
in culture medium, and in culture medium supplemented
with low concentration (3 %) of serum. Spectra recorded by
UV/vis spectroscopy in water and culture media do not
show any detectable absorbance even after 24 h, as expected
on the basis of the silica properties and the small size of the
nanoparticles. When serum is present, an unstructured ab-
sorbance typical of scattering is immediately observed, and
its intensity increases after 24 h (data not shown). Such a
behavior is likely an indication of the formation of nano-
particle aggregates driven by the presence of serum proteins.
This hypothesis was confirmed by measuring the NP
sizes with DLS upon incubation in different media
(Fig. 1). Again, the intensity-weighted distribution curves
of SM30 NPs, at concentration of 1 mg/mL, in PBS solution
and in culture medium without serum were very similar to
each other and at any time interval, showing an average
diameter of about 20 nm, a value larger than 14 nm reported
in Fig. S1, since intensity-weighted distribution plots usual-
ly slightly overestimate sizes. After addition of low
concentration of serum (3 %) to SM30 suspension in culture
medium, larger objects were detected by the DLS analysis,
with an average size of 110 nm and large size dispersion.
Such a behavior can be likely ascribed to the formation of
nanoparticle aggregates with serum components. Similar
results were obtained for suspensions at lower concentra-
tions of SM30 NPs (0.1 mg/mL) and for Ludox® AS30
(data not shown).
Cytotoxicity of Ludox® nanoparticles
Cultures of CCD-34Lu, HT-1080, and A549 cells were
incubated with increasing concentrations of Ludox® NPs
(AS30 and SM30) by adopting two treatment modalities:
incubation for long times (24, 48, and 72 h) in medium
supplemented with 3 % of serum, or incubation for short
time (2 h) in serum-free medium. We selected these treat-
ment modalities because DLS measurements showed that
NPs aggregate in presence of serum (Fig. 1), and prelimi-
nary cell viability tests suggested that 2 h is the maximum
time interval of culture in medium, without serum, tolerated
by the most sensitive cell line (CCD-34Lu) here analyzed
(data not shown). For long incubation times, we supple-
mented culture medium with 3 % of serum, which
Fig. 1 Dynamic light scattering (DLS) particle size distribution of
Ludox® NPs SM30 (1 mg/mL) suspended in PBS, in culture medium,
and in medium with 3 % of serum. The measures were performed for
each sample after 2 h incubation at 37 °C
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represents the lower percentage suitable for maintaining the
cells up to 72 h without suffering, in accordance with our
previous observations [37].
The results of MTS assay showed that the exposure to
NPs caused a significant decrease of cell viability in a dose-
and time-dependent manner, and the incubations in serum-
free medium were the most toxic (Fig. 2). Under this treat-
ment condition, cell viability strongly decreased at NP con-
centrations at which the majority of cells survived when the
treatment occurred in presence of serum. For example, the
cell viability of CCD-34Lu was about 90 % after incubation
with 0.1 mg/mL of SM30 in medium supplemented with
serum and only 20 % in medium without serum. The
colony-forming ability of cells treated with nanoparticles
has been assessed after treatments with both modalities
(Fig. 3). The results confirmed that the absence of serum
during the treatment increased the toxicity of silica nano-
particles. With few exceptions, in our experiments, SM30
and AS30 NPs caused very similar levels of cytotoxicity.
Thus, we reported here only the results obtained with
Ludox® SM30. The data of cell viability after treatments
with Ludox® AS30 are available (see Electronic supplemen-
tary material Fig. S2 and S3). The viability of CCD-34Lu
cells analyzed by MTS seems to be substantially unaffected
by treatment with 0.01–0.03 mg/mL of SM30. In contrast,
the results of clonogenic assay performed under the same
conditions markedly reduced cloning efficiency (Fig. 4). To
compare the results obtained from the two assays, we cal-
culated the concentrations of SM30 NPs able to reduce cell
viability to 50 % of the control cells (EC50 value). As
expected, with both assays, the toxicity induced by NP
incubation in medium without serum resulted in EC50 val-
ues lower in comparison with treatments carried out in the
presence of serum (Fig. 5). Moreover, in all treatment con-
ditions and in all cell lines, the clonogenic assay was more
sensitive than the MTS assay, as shown by the EC50 values
significantly lower.
Oxidative stress induced by Ludox® NPs
The formation of intracellular ROS induced by NP treatment
was evaluated by measuring the fluorescence intensity emit-
ted by 2',7'-dichlorofluorescein (DCF) formed from the in-
teraction of H2DCFDA with ROS. The level of ROS was
measured after both treatment modalities (not shown), but a
significant increase of DCF florescence has been detected
only when the measurements were performed immediately
at the end of 2-h treatment in serum-free medium (Fig. 6a).
The mean fluorescence intensity (MFI) of cells treated with
NPs (0.02 to 0.06 mg/mL) significantly increased in the two
cancer cell lines, A549 and HT-1080. At the highest con-
centration of SM30 (0.06 mg/mL), the MFI was about
seven- and fourfold over the control respectively in HT-
1080 and in A549 cells. In CCD-34Lu cells, MFI
Fig. 2 Cell viability measured
by MTS assay in HT-1080,
A549, and CCD-34 Lu cells
treated with increasing concen-
trations of Ludox® NPs SM30
in medium with 3 % of serum
(a) or without serum, followed
by a recovery for 3 or 22 h in
complete medium (10 % of se-
rum) (b). The data represent
mean±SD (3≤n≤15). *p<0.05,
**p<0.01 (t test; treated vs.
control cells)
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significantly increased over the control at very low NP
concentration (0.02 mg/mL), reached the maximum value
at 0.03 mg/mL, and markedly decreased at higher concen-
trations. To evaluate whether the decrease of the ROS level
in CCD-34Lu was correlated to a decrease of cell viability,
we measured the plasma membrane permeability to propi-
dium iodide (PI) added during the incubation with the ROS
probe. The dot plots of PI fluorescence versus DCF fluores-
cence (Fig. 6b) shows that about 33 % of cells exposed to
0.03 mg/mL of SM30 were positive to PI fluorescence,
because of the loss of plasma membrane integrity. The cells
positive to PI and negative to carboxy–DCF were probably
unable to convert the ROS probe to fluorescent compound.
In contrast, most HT-1080 and A549 cells, in which ROS
Fig. 3 Cell survival measured
by clonogenic assay in HT-
1080, A549, and CCD-34Lu
cells treated with increasing
concentrations of Ludox® NPs
SM30. Cell cloning was per-
formed after a 24-h treatment
with NPs in medium containing
3 % of serum (a), or after a 2 h
treatment in serum-free medium
followed by a recovery for 3 or
22 h in complete medium (b).
The data represent mean±SD
(3≤n≤12). *p<0.05, **p<0.01
(t test; treated vs. control cells)
Fig. 4 Cell survival of CCD-34 Lu assessed by MTS and clonogenic
assays. The cells were incubated with Ludox® SM30 for 24 h in
medium with 3 % of serum (a) or for 2 h in serum-free medium
followed by a recovery of 22 h in complete medium (b). The data
represent mean±SD from four independent experiments. Cell survival
determined by clonogenic assay was significantly lower than that
determined by MTS for all the three tested doses (p<0.001, t test,
clonogenic vs MTS). ND0not detectable
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level increased with NP concentration, were viable since
they were negative to PI (not shown).
Apoptosis induction by Ludox® NPs
We investigated the modality of cell death induced by treat-
ment with Ludox® NPs by the Annexin V–FITC/propidium
iodide double staining followed by flow cytometry analysis.
Upon activation of the apoptotic program, cells lose the
asymmetry of the plasma membrane, by translocating the
phospholipid PS on the outer leaflet of the membrane. The
double staining with Annexin V and propidium iodide
allows to distinguish cells undergoing early apoptosis (pos-
itive to only Annexin V–FITC) and cells in late stage of
apoptosis (positive to Annexin V–FITC/propidium iodide)
from necrotic cells (positive to only propidium iodide). The
analyses were performed in cells exposed for 2 h to SM30
(0.04 mg/mL) suspended in serum-free medium (Fig. 7)
since, under this treatment condition, the loss of cell viabil-
ity and the formation of intracellular ROS were much more
pronounced. The fraction of CCD-34Lu cells positive to
only Annexin V increased during post-treatment incubation
Fig. 5 Cytotoxicity of SM30 NPs expressed as half-maximum effec-
tive concentration (EC50 value in milligrams per milliliter), as assessed
by MTS and clonogenic assays. a Treatment of 24 h in medium with
3 % of serum; b treatment of 2 h in serum-free medium, followed by
recovery of 3 h in complete medium (serum 10 %) or of 22 h in
complete medium (c). The data represent mean values of EC50±SD
(3≤n≤15). In all treatment conditions and in all cell lines, the values of
EC50 derived from clonogenic assay were significantly lower than
those determined by MTS (p<0.001, t test)
Fig. 6 Reactive oxygen species
(ROS) generation in cells trea-
ted with Ludox SM30 for 2 h in
serum-free medium. a The
mean florescence intensity of
the ROS probe (carboxy-DCF)
is expressed as percentage of
control fluorescence. The data
represent mean±SE (n03). *p<
0.05, **p<0.01 (t test; treated
vs. control cells). b Dot plots
obtained from representative
experiment, showing propidium
iodide (PE) versus carboxy-
DCF fluorescence (FITC) in
CCD-34Lu cells; left panel:
untreated cells; right panel:
cells treated with SM30
(0.03 mg/mL) for 2 h in serum-
free medium
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from 34 % (3 h) to 51 % (22 h), considering the total cells in
early and late stage of apoptosis. In cancer cells, this fraction
was lower at both time points after treatment: 30 % in HT-
1080 cells and 9–11 % in A549 cells. We also checked by
DAPI staining the cells treated for 2 h with SM30 NPs
followed by 22 h of post-treatment incubation for presence
of apoptotic bodies formed during the late phase of apopto-
sis (Fig. 7a). Apoptotic index, calculated as percentage of
apoptotic bodies, significantly increased in HT-1080 and in
A549 cells but not in CCD-34Lu (Fig. 7b); moreover, no
apoptotic bodies were detected when the three cell lines
were subjected to long NP-incubation in presence of serum
3 % (not shown).
The induction of apoptosis in HT-1080 cells was caspase-
dependent, as detected by fluorimetric assay of caspase-3
activation performed at the same time of DAPI staining
(2 h+22 h). In this cell line, the activation of caspase-3
increased eight times over control cells whereas, in A549
and CCD-34Lu, the fluorescence intensity was almost the
same as in control (data not shown).
DNA double-strand breaks induced by Ludox®
nanoparticles
The DNA-damaging effects of NPs were assessed on the
basis of the induction of DNA DSBs by scoring nuclei for
the presence of foci of histone γ-H2AX, a reliable marker of
DSBs. The cells were incubated with SM30 and AS30 NPs
(0.01–0.4 mg/mL) in medium serum-free or supplemented
with serum. No foci were detected in CCD-34Lu and A549
cells under all treatment conditions, as well as in HT-1080
cells incubated with NPs in medium supplemented with
serum (data not shown). On the contrary, a consistent num-
ber of γ-H2AX foci was detected when HT-1080 cells were
exposed to NPs in serum-free medium (Fig. 8a). In Fig. 8b,
we reported the percentage of foci-positive cells at the end
of 2 h incubation with 0.04 mg/mL of SM30 and after 22 h
of recovery in complete medium. The fraction of cells
positive for γ-H2AX foci grew from 32 % in untreated cells
to 55 % in treated cells at the end of 2 h incubation and
significantly decreased 22 h after (38 %). The rejoining of
DNA double-strand breaks was also analyzed on the basis of
the number of foci/nucleus. HT-1080 cells positive for γ-
H2AX foci were classified in three groups having 5–10, 11–
20, and more than 20 foci/nucleus. Figure 8c shows that the
cells with more than 20 foci/nucleus were 33 % at the end of
treatment and decreased to 13 % 22 h later, fitting the
progression of DNA repair.
Discussion
Although nanomaterials are applied in many fields that seem
to be destined to increase, the mechanisms involved in the
Fig. 7 Apoptosis induction in cells treated with Ludox® SM30
(0.04 mg/mL) for 2 h in serum-free medium, followed by a recovery
of 3 (a) or 22 h (b) in complete medium. After the recovery, the cells
were double-stained with Annexin V–FITC/propidium iodide and an-
alyzed by flow cytometry to detect cells in the early or in the late stage
of apoptosis. Data represent means±SD (n03). *p<0.05, **p<0.01,
***p<0.001 (t test; treated vs. control cells). The presence of apoptotic
bodies (apoptotic index) was checked by DAPI staining at the end of 2
+22 h treatment (***p<0.01, t test, treated vs. control cells)
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induction of cytotoxicity remain not completely clarified.
The purpose of our work was to evaluate the level of the in
vitro cytotoxicity induced by commercial silica nanopar-
ticles of two different sizes, Ludox® SM30 and AS30. We
used DLS and TEM to evaluate size distribution, state of
dispersion, and Zeta potential of Ludox® NPs prior to
setting up the experiments with three different cell lines.
The little differences in particle sizes measured by DLS
(AS30, 20±4 nm; SM30, 14±4 nm) and TEM (AS30,
18±3 nm; SM30, 9±3 nm) reflect the typical difference
between the mean hydrodynamic diameter (measured by
DLS) and the “real” size (measured by TEM), the first being
larger, as usually reported for particles in solution [38]. The
Zeta potential values are above the −30 mV threshold com-
monly considered to ensure stability to a dispersion of nano-
particles stabilized by electrostatic repulsion forces. Still, in
preliminary experiments, we did not detect any aggregation
either in PBS or in culture medium. On the other hand,
Ludox® NPs strongly aggregated when the medium was
supplemented with serum, even in small amounts (3 %),
and even with very low NP concentrations (0.01 mg/mL, not
shown). Such a behavior is completely consistent with the
well-known protein flocculation ability of silica nanopar-
ticles that is exploited in many applications as beverage
clarification. The interaction of NPs with serum proteins
results in formation of large aggregates with an average size
of 110 nm, as resulting from the DLS analysis reported in
Fig. 1, immediately after diluting NPs with medium supple-
mented with 3 % of serum. Likely, the aggregation process
continues with the time of incubation, as suggested by the
increased scattering observed in NP suspensions by UV/
visible absorption experiments (data not shown). The ad-
sorption of plasma proteins onto the surface of nanostruc-
tures represents a well-known problem for the successful
application of nanobiotechnology and nanomedicine [39],
and many studies have been performed during the last few
decades on passivating surfaces of nanomaterials [40–42].
In order to assess the cytotoxicity of Ludox® NPs, we
exposed cells to different incubation strategies: short incu-
bation (2 h) in serum-free medium or long incubation (24–
Fig. 8 Induction of DNA double-strand breaks in HT-1080 cells. a
Immunofluorescence of γ-H2AX foci in HT-1080 treated with Ludox
® AS30 and SM30 NPs in serum-free medium. b Percentage of HT-
1080 cells positive for γ-H2AX foci after 2 h incubation with 0.04 mg/
mL of SM30 NPs in serum-free medium. Cells were fixed at the end of
treatment (2 h) and after a recovery of 22 h in complete medium (2+
22 h). c Positive cells for γ-H2AX foci were categorized on the basis of
the number of foci/nucleus (5–10, 11–20, >20 foci). Data represent
means±SD (2≤n≤4). *p<0.05, **p<0.01, t test, treated versus control
cells; °p<0.05, t test, (2 h) versus (2+22 h) treated cells
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72 h) in serum-containing medium. This choice is related to
the importance of considering either the time of incubation
with NPs, and the presence/absence of serum during treat-
ments, as significant variables in assessing NPs toxicity, in
accordance with literature data [30, 43]. Indeed, when the
nanoparticles enter the body, the cell–nanoparticles interac-
tions occur through biological protein-rich fluids, as well as
in protein-free or protein-poor conditions. The duration of
incubation time in serum-free medium and the percentage of
serum (3 %) supplemented in the long incubation protocols
were checked in our preliminary experiments to assure that
such conditions did not affect by themselves cell viability
(not shown). As expected, cell treatments performed with
Ludox® NPs suspended in medium with or without serum
gave different results. Cell viability assays showed little or
lower cytotoxicity when treatments occurred in presence of
serum, suggesting that NP aggregation induced by serum
components decreased their toxicity. Our results are in ac-
cordance with those reported in 3T3 cells treated with silica
NPs in presence of increasing concentrations of serum [30],
probably as a consequence of the lower cellular uptake of
NPs suspended in serum-containing medium compared with
serum-free medium [29]. A lower level of cytotoxicity has
been observed in a murine macrophage cell-line exposed to
manufactured NPs (polystyrene beads) suspended in
medium-containing serum than in medium without serum
[43]. We believe that, when NPs are monodisperse or form
small aggregates, they penetrate across cell membrane, and
the deleterious effects are caused by the accumulation of
NPs in the cytoplasm or in vesicles, as observed for other
silica nanoparticles with similar sizes [30, 35, 44]. Under
long treatment modality, NPs form aggregates that probably
sediment over cell monolayers, without penetrating into the
cells. Therefore, the cytotoxicity observed following long
NP incubations is very likely caused by damages on plasma
membrane that impair its functions. The variation of cyto-
toxicity of silica NPs as a function of their agglomeration
behavior has been reported also in HeLa cells [45] and in
blood cells [46].
Previous reports [10, 12, 14] have shown that NPs
with small diameter and large surface area/volume ratio
induce higher cytotoxicity in comparison with the larger
NPs, probably because they were easily internalized by
the cells, and, at the same weight/volume of the medi-
um, they were also administered in larger number. The
dimensions of Ludox® NPs used in the present work
are quite similar, being SM30 9 nm, in accordance with
previous results [35], and AS30 18 nm. In our experi-
ments, the different stabilizing counterions did not affect
the toxicity induced by NPs; indeed, with few excep-
tions, SM30 and AS30 NPs caused very similar levels
of cytotoxicity, in accordance with their similar sizes
(Fig. S1).
To determine the critical concentrations for the exposures
to nanomaterials, a careful selection of testing strategies is
also required. The most common methods used in assessing
the in vitro cytotoxicity of nanomaterials are colorimetric
assays (i.e., MTT, MTS, XTT, etc.), in which tetrazolium
salts are reduced to formazan by metabolically active cells,
producing measurable color changes proportional to the
number of viable cells. Although useful to assess cell via-
bility, these assays provide little input in determining the
retention of proliferation ability of treated cells. Indeed, they
measure cell viability as a function of metabolic activity of
cellular dehydrogenases, without considering cell cycle per-
turbations and cell proliferation alterations. As a conse-
quence, the cytotoxic potency of nanoparticles could be
underestimated by the results from short-term assays. For
this reason, we assessed the cytotoxicity of Ludox® NPs
also with the long-term clonogenic assay, based on the
number of colonies formed from single cells. By comparing
the results obtained by the two assays, we observed that
EC50 calculated from clonogenic assay was always lower
than that measured by MTS assay. In particular, in HT-1080
and CCD-34Lu cells treated with long treatment modality,
the values of EC50 were 20- to 30-fold lower when calcu-
lated from the data of clonogenic than MTS assay, and two-
to fivefold lower in all the three cell lines subjected to short
treatment modality (Fig. 5). This result reflects the different
sensitivity of MTS and clonogenic assays, based the first on
enzymatic activities detected either in viable and in senes-
cent/dying cells, and the second on the retention, by only
viable and healthy cells, of proliferation ability. Moreover,
by performing clonogenic assays at 3 or 22 h from the end
of NP incubation, we obtained information on cellular re-
cover from stress induced by treatments (Fig. 3b). The
survival of CCD-34Lu and A549 cells was very similar at
both time points, suggesting that these cell lines did not
recover during post-treatment incubation and the toxicity
induced by NP treatment persisted for long time. Instead,
HT-1080 cells recovered part of their proliferation ability
during the post-treatment incubation, at least when the NP
concentration was low (<0.03 mg/mL). When cells were
incubated for 24 h in medium supplemented with 3 % of
serum, cell survival similarly decreased with dose in HT-
1080 and CCD-34Lu cells, and at the dose 0.1 mg/mL, only
0–20 % survived, in contrast to 80 % of A549 cells
(Fig. 3a). Noteworthy are our results showing that NP con-
centrations, which seem non-toxic on the basis of MTS data,
are instead able to inhibit cell proliferation at doses threefold
lower.
The toxicological mechanisms of Ludox® NPs were dif-
ferent among the three cells lines assayed in our experi-
ments. Many studies reported the oxidative stress as the
main mechanism of silica nanoparticle-induced toxicity re-
sponsible for cell damages [12, 15, 16, 18, 22, 44, 47]. In
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CCD-34Lu, intracellular ROS generated by NP treatments
were detectable only at low concentrations (up to 0.03 mg/
mL), while, at higher doses, ROS production increased
weakly over control (Fig. 6). It seems likely that, in these
cells, the mortality induced by NPs was due to the high
sensitivity of their plasma membrane, which became severe-
ly damaged probably as a consequence of lipid peroxida-
tion, as observed in other cell line exposed to different kind
of nanoparticles [48, 49]. Indeed, in treated CCD-34Lu, we
observed that phosphaditylserine translocated to the outer
leaflet of plasma membrane, but the progression of apopto-
tic program was halted by the loss of plasma membrane
integrity, demonstrated by the propidium iodide staining. As
a consequence, apoptotic bodies, which represent the final
step of apoptosis, were missing in these cells that probably
switched to necrosis.
In cancer cells, and in particular in HT-1080, ROS pro-
duction was higher than in normal fibroblasts and increased
with NP concentration at least up to the highest tested dose.
It was observed that intracellular ROS can cause DNA
damages, in the form of single- and double-stranded DNA
breaks, base modifications, and DNA cross-links, all of
which are involved in initiating and promoting carcinogen-
esis [50]. Moreover, high ROS concentrations are able to
activate caspase-3 [49, 51, 52], the pivotal protein in the last
phase of apoptosis. At the end of incubation with 0.04 mg/
mL of Ludox® SM30 in medium without serum, ROS level
in HT-1080 cells significantly increased over control, as
well as caspase-3 activity, apoptotic index, and DNA
double-strand breaks. A549 cells subjected to the same
treatment conditions showed moderate increases of intracel-
lular ROS and apoptosis, and no induction of DNA strand
breaks, in accordance with data from the same cells sub-
jected to long incubation with high concentrations of multi-
walled carbon nanotubes or silica nanoparticles [38, 53, 54].
The induction of oxidative stress responses have been
reported also in a neuronal cell line after exposure to Ludox
AS-20 and AM nanoparticles [55].
On the whole, our data show that Ludox® NPs suspended
in medium supplemented with serum are unstable and tend
to form aggregates, which are toxic for all the three cell lines
at concentrations five to tenfold higher than when adminis-
tered as monodisperse suspensions in serum-free medium.
Notably, under short and long treatment modalities, NP
concentrations which seem non-toxic on the basis of MTS
data are instead able to inhibit cell proliferation at doses at
least threefold lower. Our findings are particularly valid for
proliferating cells of regenerating epithelia of respiratory
and gastrointestinal tracts, where the exposure to nanopar-
ticles can occur by inhalation and ingestion. Indeed, inhaled
or ingested NPs may translocate toward the inner tissues,
inducing toxicity to proliferating and stem cells of such
tissues.
In conclusion, our results highlight the importance of the
choice of the testing assays when evaluating cytotoxicity of
silica NPs in cell cultures. Indeed, we provide evidence that
long-term cytotoxicity assays represent a more appropriate
method for accurate and efficient testing of the potential
hazards of nanomaterials. Therefore, proper studies compar-
ing the toxicity data obtained with both short-term and long-
term assays should be employed when measuring the cell
response to nanoparticle exposure.
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